IDEA #2BRORGABANDONED, per CSMC 20190826 3:02 PM email to N Mitra.
Using Dual GLP-1/GIP Receptor Agonists To Treat Brain Insulin Resistance, Mild Cognitive Impairment and Alzheimer's Disease Dementia
For more information or to license this innovation: